Joining the Fight Against Colorectal Cancer

Joining the Fight Against Colorectal Cancer

text in red and blue lettering

Colorectal cancer (also known as CRC) is the second leading cause of cancer death among men and women combined in the U.S.1 It’s predicted that 52,580 people will die from CRC in 2022.1 In only eight years, colorectal cancer is predicted to be the leading cause of cancer deaths for those between ages 20-49.2

While colorectal cancer is curable if diagnosed early and treated properly, statistics point to barriers to screening and treatment:

  • Black Americans are less likely to have a colonoscopy,3 more likely to be diagnosed with late-stage disease and have poorer outcomes following diagnosis.In addition, less than 50 percent of Asian Americans are screened regularly.5
  • People with low socioeconomic status also face a poorer prognosis, with reasons ranging from differences in risk factors (such as dietary and other behavioral factors) to fewer screenings and access to treatment.6

At Daiichi Sankyo, we are committed to this important community and the many dedicated advocacy groups that serve them. This Colorectal Cancer Awareness Month, we will join our advocacy partners in helping to raise awareness of barriers to screening and access to treatment. You can play a part by participating in annual colorectal cancer awareness programs throughout March. If you’d like to participate, simply:


  1. Join Fight Colorectal Cancer’s annual #StrongArmSelfie campaign to support the colorectal cancer community. 
  2. Take the Colorectal Cancer Alliance pledge to speak with your healthcare provider about screening options.
  3. Submit a name and message to display in honor of a loved one at the United in Blue flag installation in D.C. from March 13 – 18.

Gestures of support and compassion like these are incredibly important. Follow us on Twitter at @DaiichiSankyoUS throughout the month as we advocate for those in the colorectal cancer community – and all patients – who face care inequities. You can also contact our Head of Global Advocacy for Oncology Gissoo


[i] Key Statistics for Colorectal Cancer. Accessed March 9, 2022.

[ii] Rahib et al. (2021) Estimated Projection of US Cancer Incidence and Death to 2040. JAMA Network Open. 4(4), e214708.

[iii] Bromley EG, May FP, Federer L, Spiegel BM, van Oijen MG. Explaining persistent under-use of colonoscopic cancer screening in African Americans: a systematic review. Prev Med. 2015 Feb;71:40-8. doi: 10.1016/j.ypmed.2014.11.022. Epub 2014 Dec 4. PMID: 25481094; PMCID: PMC4329030.

[iv] Siegel RL, Miller KD, Fuchs HE, Jemal A. Cancer Statistics, 2021. CA Cancer J Clin. 2021 Jan;71(1):7-33. doi: 10.3322/caac.21654. Epub 2021 Jan 12. Erratum in: CA Cancer J Clin. 2021 Jul;71(4):359. PMID: 33433946.

[v] Facts and Stats. Accessed March 9, 2022.

[vi] Carethers JM, Doubeni CA. Causes of Socioeconomic Disparities in Colorectal Cancer and Intervention Framework and Strategies. Gastroenterology. 2020;158(2):354-367. doi:10.1053/j.gastro.2019.10.029